According to a study published Friday in the Journal of Molecular Diagnostics, the future of colorectal cancer screening may lie in the development of biomarkers for the disease.
South Korean researchers from Genomictree Inc. and Yonsei University College of Medicine in Seoul found that alterations of a certain gene could discriminate pretty accurately between blood samples from people with cancer and blood samples from people without cancer. Experts say that the blood test findings, while “not quite ready for prime time,” are promising.
Finish reading this article at NBC.com